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We demonstrate that the expression of extensively modified and secreted heterologous proteins synthesized in the baculovirus expresslon vector 
system (BEVS) depends on the temporal nature of the promoter transcribing the foreign gene. TheB subunit of the human chorionic gonadotropin, 
an extensively modified secretory glycoprotein hormone was expressed under the transcriptiona control of the AcNPV baste protein gene promoter 
(MP) and the polyhedrin gene promoter (POL), respectively. MP, activated late in the infection cycle, is a weaker promoter when compared to 
the stronger very late POL promoter. Levels of secretion, immunoreactivity and bioactivity of recombinant proteins, /3hCGso, and /?hCG,, 
synthesized under control of the MP and POL promoter were compared. Secretion ofbhCG,, was relatively higher. Enzymatic analysis revealed 
that the synthesized protein was sialylated. Receptor binding assays and testosterone stimulation assays in a mouse Leydig cell system demonstrated 
that on a umt protein basis, j?hCGhfp was btologically more active than j3hCGroL. 
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1. INTRODUCTION 
The baculovirus expression vector system (BEVS) 
uses a helper-independent virus that can hypertran- 
scribe and express to very high levels, in lepidopteran 
cell lines and caterpillars, a foreign gene placed under 
the control of the very late polyhedrin gene promoter. 
BEVS is very widely used since the recombinant protein 
synthesized in this system is similar to its authentic 
counterpart in terms of immunoreactivity, immunogen- 
icity and bioactivity [ 11. However, it has been commonly 
observed that membrane-associated, secretory or heav- 
ily glycosylated proteins are expressed in relatively 
lower amounts. HBsAg, for instance is only partially 
secreted to a level of 0.3 mg/l at five days post-infection 
(p.i.) [2]. Human multidrug transporter [3] and the 
chorionic gonadotropin OL subunit [4] which are secrc- 
tory glycoproteins as well as preproattacin [S] have been 
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control. 
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shown to be inefficiently secreted. On the other hand, 
genes encoding non-secretory proteins such as lucif- 
erase [6], influenza virus hemagglutinin [7], bovine leu- 
kemia virus p34 protein [8], the bluetongue virus NSl 
protein [9] etc. are expressed to much higher levels, at 
times comparable with that of polyhedrin. This phe- 
nomenon of bias against secretory proteins is more evi- 
dent using a recombinant dual expression virus carrying 
a secretory and non-secretory gene, where expression of 
the non-secretory protein is severalfold higher than the 
secretory one, even though the genes encoding them are 
placed under identical transcriptional control [lo]. 
Therefore, the amount of biologically and functionally 
active protein synthesized in BEVS is not solely depend- 
ent on the strength of the promoter. 
We previously reported the expression and bioactiv- 
ity of the a-subunit of hCG [4]. ahCG, a glycosylated, 
secretory protein, was shown to be inefficiently secreted 
with the bulk of the expressed protein remaining behind 
in the cell pellet as compared to the supernatant. This 
was because of overexpression of protein which could 
not be completely processed and secreted within the 
short time available prior to cell death caused by the 
lytic nature of the virus. This ‘secretory load’ [4] is the 
manifestation of the inability of the cells to cope with 
the rapidly accumulating mass of foreign protein syn- 
thesized under transcriptional control of the hyperac- 
tive and temporally regulated very late polyhedrin (~29) 
gene promoter. The p10 promoter. another strong but 
very late promoter or the synthetic promoter carrying 
the consensus equence of the polyhedrin and p10 pro- 
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moters used in this system face somewhat similar prob- 
lems [I l-l 31. Here, we describe the results of expression 
of the j? subunit of hCG, a heavily glycosylated, secre- 
tory and complex protein, under the viral polyhedrin 
and basic protein (MP) promoters. The MP promoter 
is weaker than the polyhedrin promoter and peaks in 
activity at an earlier time p.i. [14], thus giving more time 
for post-translational modifications between promoter 
activation and cell lysis. Using /?hCG as a reporter, we 
show that the temporal nature of the activation of the 
promoter and not its relative strength is responsible for 
efficient secretion, glycosylation and bioactivity of re- 
combinant /3hCG. We also show that insect cells are 
indeed capable of sialylating the expressed protein. 
infection with vAc/3hCG,, and vAc#hCG,, and the culture superna- 
tant was centrifuged at 100,000 x g for 1 h at 4°C to precipitate the 
virus particles. An affinity column carrying immobilized monoclonal 
antibody specific tofiCG was pre-equilibrated with 0.01 M Tris-HCI, 
pH 8, containing 0.14 M NaCl which was recirculated overnight to 
which the virus-free culture supernatant containing the secretory, re- 
combinant j?hCG was loaded. The column was then washed once with 
10 mM Tris-HCI, pH 8 containing 0.14 M NaCl and twice with 50 mM 
Tris-HCI, pH 8 containing 0.5 M NaCI, 0.1% Triton X-100. The 
recombmant j?hCG protein was eluted with 0.05 M glycine buffer pH 
2.3 containmg 0.15 M NaCl[20]. Peak fractions were pooled, dialysed 
and the concentration of the recombinant purified protem determined 
by RIA. Purified protein was characterised by Western blotting as 
described [17,21]. Commercially available sialic acid detection 
(Boehringer Mannheim) was used as per the manufacturer’s recom- 
mendations for quantitative estimation of sialic acid residues. Urinary 
BhCG was used as an external control. 
2. MATERIALS AND METHODS 3. RESULTS AND DISCUSSION 
2.1. Construction, purification and characterlsarion of recombinant ri- 3.1. Expression, secretion and bioactivity of PhCG 
ruses 
The 539 bp BhCG cDNA was excised from pBS2 [15] as a BgfII 
fragment. This was placed separately under the transcriptional control 
of the polyhedrin promoter and the basic protein promoters to con- 
struct recombinant transfer vectors pVc#?hCG,, and pAcj?hCG,,, 
respectively. The recombinant plasmids were characterized by restric- 
tion enzyme digestion and in-gel hybridisation [16] for the presence of 
the /3hCG gene insert in the correct orientation with respect to the 
corresponding promoter. Recombinant baculoviruses vAc/lhCG,, 
and vAc#hCG,, were isolated, purified and titrated as before [17]. 
2.2. Synthesis and bioactivity of hCG 
Identical titres of each recombinant virus was used to infect Sf9 cells 
seeded in 24-well plate. /3hCG expression in the culture supernatant 
was monitored at 12,24,36,48 and 72 h p.i. by a subunit specific RIA 
[15]. The amount of hCG as estimated by RIA was normalized to 1 
pg in each case and incubated with a large molar excess of purified 
standard ahCG for 16 h at 37°C. The ahCG/phCG dimer was quan- 
titated using a rat testicular receptor bmding assay [I81 and a mouse 
Leydig cell bioassay [19] with appropriate modifications [17]. 
2.3. Purificatron and analysu of recombinant protezn 
Suspension cultures of Sf9 cells were infected at high multiplicity of 
Partial restriction maps of pVcj?hCGpo,_ and 
pAcBhCG,r showing the direction of transcription of 
the ,BhCG gene under the different promoters are de- 
picted in Fig. 1. St9 cells seeded in a 24-well plate were 
infected with the same titre of vAcphCGpoL and 
vAcj3h CG,, and at different times p.i., the culture su- 
pernatant was assayed for the presence of ,5hCG using 
RIA. In vAc/?hCG,,,, the peak of /?hCG production 
followed the kinetics of the polyhedrin promoter activ- 
ity giving 2.8 pug/2 x lo6 at 48 h p.i. reaching a maximum 
level of 9.05 ,~@2 x lo6 cells at 72 h p.i. whereas, in 
vA$hCG,, the peak of /?hCG secretion reached 11.3 
&2 x IO6 cells at 48 h p.i. (Fig. 2A). As would be 
expected, the levels of secretory protein were relatively 
higher under the control of the MP promoter at initial 
time p.i. hCG is a heteromeric protein composed of two 
subunits. 01 and /I. The individual subunits of hCG on 
their own have no biological activity and require to 
associate with the corresponding subunit to give a bio- 
CA) SnrRI 
EcoRI PVUII 
ca 
BhCG- puce 
CB) SE-1 
Em-RI PVUII 
PVUII C643S> 
BhCG - puce 
Fig. 1. Partial physical maps of recombinant plasmids pV@hCG,, (A) and pAc@hCG,, (B). The Integration of the BhCG gene under the control 
of the polyhedrin (POL) promoter and the basic protein (MP) promoter, respectively, IS illustrated (not drawn to scale). Those restriction sites used 
for checking the orientation of the insert with respect to the promoter are indicated. The sequences upstream and downstream of the foretgn gene 
are identical to the polyhedrin gene flanking sequences present in the viral DNA to enable homologous recombmation at the polyhedrin locus. 
The numbers indicate the positions of different restriction enzyme sites in the recombinant transfer vector with respect to the nucleotide ‘A’ within 
the 5’ EcoRI site of the viral EcoRI-I fragment. 
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Table I Secretory levels of PhCG. 
Sialic acid analysis of recombinant BhCG 
FEBS LETTERS January 1993 
% sialic aad 
Native BhCG 10 
BhCG 6.3 
/?hCG 8 
logically active a@ heterodimer. The recombinant PhCG 
was checked for its biological activity. Mock-infected 
cells showed no activity. It is interesting to note (Fig. 
2B) that BhCG showed higher levels of the biologi- 
cally active molecules when compared to j3hCG (80% 
vs. 40%). 
3.2. PuriJication and analyses of recombinant protein 
Recombinant j&CC was purified from culture super- 
natant by immunoaffinity using the specific monoclonal 
antibody to BhCG and characterised on SDS-PAGE. 
This was further immunoblotted to confirm the authen- 
ticity of the eluted sample. The recombinant fihCG pro- 
duced in insect cells exhibited increased electrophoretic 
mobility when compared to the native j?hCG purified 
from urine of pregnant women. Native /IhCG was de- 
tected as a 33 kDa band while the recombinant protein 
was approximately 23 kDa (Fig. 3). In spite of the dif- 
ference in mobility, there was no loss of immunoreactiv- 
ity of the insect-derived j?hCG. 
The difference in electrophoretic mobility was attri- 
buted to differences in the level of glycosylation of the 
proteins and not to the amino acid backbone per-se 
since total amino acid analysis of native BhCG, 
j?hCG and /IhCG did not show significant differ- 
ences (data not shown). Digestion with sialidase (neu- 
raminidase) was carried out, using a commercial sialic 
acid detection kit, to check for the ability of the insect 
cell system to sialylate. Results (Table I) demonstrated 
the presence of sialic acid residues on the recombinant 
St9-derived protein and the degree of sialylation be- 
tween the two recombinant proteins (BhCG, 
BhCG) was quantitatively different. 
We have used two different promoters to direct the 
transcription of the j?hCG gene and evaluated the ex- 
pression of the /I subunit of hCG in insect cells using 
BEVS. The very commonly used AcNPV polyhedrin 
gene promoter is activated very late in the viral life cycle 
and soon after the occlusion bodies are formed, cell lysis 
occurs due to the lytic nature of the baculovirus. Poly- 
hedrin, being a non-secretory, non-glycosylated pro- 
tein, is expressed to very high levels to occlude the viral 
particles, following which cell death occurs. It has al- 
ready been shown previously [2,3,6,8,9] that expression 
under polyhedrin promoter control varies considerably, 
which could be attributed to various factors. Presence 
of specific sequences around the ATG [22], secondary 
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Fig. 2. Time course and biologtcal activity of fiCG synthesized m 
insect cells infected with vAc,tIhCG and vA@hCG. (A) Recombt- 
nant baculoviruses vAcj3hCG and vAc$hCG were isolated, puri- 
fied and titrated. Identical titres of each recombinant virus were used 
to infect St9 cehs seeded in 24-well plate. BhCG expression m the 
culture supe~atant was monitored at 12, 24, 36, 48 and 72 h pi. by 
a subunit-specrfic RIA. (B) Biological activity of BhCG and 
jhCG. Supernatant from infected cells was incubated with a molar 
excess of purified standard ahCG for 16 h at 37°C and the ahCG/ 
BCG dimer was quantitated using a Leydig cell bioassay. These 
results are the average of at least five experiments and vartations 
between experiments were less than 10 ng. 
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kD 
Fig. 3. SDS-PAGE of affinity purified j?hCG,,, BhCG,, and native, 
urinary fiCG. 
structure of the foreign gene transcript and mRNA sta- 
bility, amongst others, could be responsible. In BEVS, 
the cellular machinery has an important role to play in 
carrying out the various post-translational modifica- 
tions. An intact, functional system is required if an effi- 
ciently processed product is to be synthesized which will 
not be possible if cell lysis occurs soon after the produc- 
tion of the recombinant protein. In a recent study [23], 
a time course of HIV envelope protein expression re- 
vealed that at early times p.i. (24 h) the proteins were 
fully glycosylated and soluble in non-ionic detergents. 
However, at 48 h p.i. and onwards, expression levels of 
the recombinant protein reached a maximum but most 
of the increase was due to a rise in the level of non- 
glycosylated species which were largely insoluble. Thus, 
it appeared that St9 cells could not process large 
amounts of recombinant products very efficiently. An- 
other recent study [24] demonstrates that lepidopteran 
cells require long periods of time p.i. with a recombinant 
virus to carry out complex oligosaccharide processing 
as shown using human plasminogen as a reporter. At 
early times p.i., there is a preponderance of high-man- 
nose type oligosaccharides on the protein, whereas at 
late times p.i. (60-96 h) most of the oligosaccharides 
exist as complex carbohydrates. 
We worked on the assumption that an extensively 
processed protein can be efficiently expressed and se- 
creted to high levels not by using a strong promoter, but 
by advancing the activation of transcription of the gene 
such that the cells are given enough time between the 
peak of protein expression and cell death. BhCG was 
chosen as a model because it provides a typical example 
of a protein where extensive post-translational modifi- 
cations are necessary for biological activity. /?hCG is 
extensively glycosylated (33-36%) with four O-linked 
and two N-linked groups [20], besides the presence of 
sialic acid residues. The sugars play an important role 
in secretion, subunit assembly, biological activity and 
stability of hCG [25]. The molecule has six intrachain 
disulphide bonds which are very important for the na- 
tive conformation of the molecule. Reduction of these 
bonds leads to a loss of receptor recognition. This very 
complex nature of j?hCG protein involving extensive 
post-translational modifications, processing and proper 
folding makes it an excellent reporter for our study. The 
gene encoding /?hCG, was separately cloned under the 
control of both the polyhedrin promoter as well as the 
basic protein promoter MP. The basic protein is an 
essential structural protein of the virus which is ex- 
pressed earlier in the viral life cycle than polyhedrin [14]. 
Relatively early transcription from the MP promoter 
(12-24 h) compared to the polyhedrin promoter (2472 
h) has also been demonstrated using the /I-galactosidase 
protein as a reporter where it was also shown that MP 
is a significantly weaker promoter in terms of its tran- 
scriptional activity when compared to the very late pol- 
yhedrin gene promoter [14]. This therefore provides a 
good system to directly measure the importance of pro- 
moter strength versus time of promoter activation for 
the efficient synthesis, secretion and bioactivity of a 
complex protein like BCG. 
The MP promoter allows the cells a longer time pe- 
riod between the peak of expression and cell lysis during 
which time the processing pathways do not get compro- 
mised which otherwise happens when the foreign gene 
is expressed under control of the polyhedrin promoter. 
Data in Figs. 2 and 3 show that immunologically active 
BhCG,, is more efficiently secreted than /?hCGm, in 
spite of the fact that the former is the result of transcrip- 
tion from a comparatively weaker promoter. The in- 
creased time available, when transcribed relatively early 
in the infection cycle under MP promoter control, al- 
lows proper processing and extracellular transport. In 
a parallel situation, we recently showed [17] that the 
extended time available to Spodoptera larvae upon in- 
fection with a recombinant baculovirus results in hCG 
of a better quality in terms of bioactivity. It was gener- 
ally believed that lepidopteran cells are unable to per- 
form sialylation. Sialic acids, however, play an impor- 
tant role in a number of biological processes and their 
expression has been very recently correlated with devel- 
opmental regulation and early embryogenesis in D. 
melanogaster [26]. Our observation that the baculovirus 
system cannot only sialylate but that the degree of sia- 
lylation can also be manipulated, should enable a more 
critical evaluation of the role of sialic acid in cellular 
processes. j?hCGlllP has a higher percentage of biologi- 
cally active molecules per unit mass of protein than 
BhCG,o, and this correlates very well with the differ- 
ence observed in the level of glycosylation (data not 
shown) between the two recombinant proteins since it 
is well documented that glycosylation is indeed impor- 
tant for signal transduction leading to steroidogenesis 
[27,28]. Perhaps, carbohydrates favour proper folding 
of the subunit resulting in a molecule which can more 
efficiently interact with the cellular receptors leading to 
285 
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more efficient transduction of signal(s) for testosterone 
production. It should be possible now to address spe- 
cific questions about the role of carbohydrates in fold- 
ing/bioactivity of hCG or similar molecules. 
The present work clearly demonstrates that the tem- 
poral nature of a promoter is a more important charac- 
teristic than relative strength for the expression of a 
gene. This has important implications in using the MP 
or similar promoters activated earlier in the infection 
cycle [29] for the expression of highly processed proteins 
since the use of a strong promoter does not necessarily 
confer any advantage by virtue of its strength [30] in 
such situations. This approach of temporal expression 
can be successfully used to produce more efficiently 
similar proteins, of biomedical and therapeutic uses, 
which require extensive post-translational modifica- 
tions and processing for their bioactivity. The capability 
of the baculovirus system to sialylate makes it more 
versatile for expressing proteins where sialylation is nec- 
essary. 
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